Techniques are disclosed for detecting arrhythmia episodes for a patient. A medical device may receive one or more sensor values indicative of motion of a patient. The medical device may determine, based at least in part on the one or more sensor values, an activity level of the patient. The medical device may determine a heart rate threshold for triggering detection of an arrhythmia episode based at least in part on the activity level of the patient. The medical device may determine whether to trigger detection of the arrhythmia episode for the patient based at least in part on comparing a heart rate of the patient with the heart rate threshold. The medical device may, in response to triggering detection of the arrhythmia episode, collect information associated with the arrhythmia episode.

A system and methods of maintaining communication with a medical device for exchange of information, instructions, and programs, in a highly reliable manner. Apparatus and methods for accomplishing this task include: 1) The inclusion of a locating device in the system, in close proximity to an implanted device, but which does not drain the implanted device battery. 2) The use of motion detection and global positioning system devices to locate elements within a communicating system for the medical device; 3) The assessment of received signal quality by elements of the system; 4) The use of a notification system for a device user who is moving out of range of communications; and 5) Documenting the absolute and functional integrity of instructions received by the medical device. A method of assuring the identification of communication participants is presented.

A method of localizing brain regions for the purpose of guiding placement of electrodes and related implants is disclosed. The inventive method involves effecting a pulse in a patient's brain, temporally aligning readings taken from an electrode at various depths, measuring local field potentials at each depth during interstimulus intervals, performing a coherence analysis comparing the local field potential measurements of the different depths, and determining a corresponding brain region for the depths compared.

A neurostimulation system comprises a control system configured to monitor a patient receiving neurostimulation therapy. The neurostimulation therapy has a stimulation cycle comprising a stimulation ON period, in which the patient is receiving neurostimulation, and a stimulation OFF period, in which the patient is not receiving neurostimulation. The control system is programmed to receive electrocardiogram (ECG) data from the patient receiving the neurostimulation therapy. The control system is further programmed to monitor a heart rate of the patient based on the ECG data over at least one stimulation cycle of the neurostimulation therapy. The control system is further programmed to generate an indication of signal stability to be displayed to a user based on the received ECG data.

In some embodiments, a method of increasing cognitive function and/or treating a disease or disorder associated with decreased cognitive function in a subject is provided. Treating a subject with an glutamate receptor agonist can include identifying the subject as an glutamate receptor agonist responder. The method can further include obtaining an electroencephalogram (EEG) signals from the subject. The method can further include measuring one or more EEG metrics, thereby identifying the subject as a glutamate receptor agonist. Further provided non-transitory processor-readable medium storing code with instructions for identify glutamate receptor agonist responders

An implantable medical device (IMD) has a housing enclosing an electronic circuit. The housing includes a first housing portion, a second housing portion and a joint coupling the first housing portion to the second housing portion. A polymer seal is positioned in the joint in various embodiments. Other embodiments of an IMD housing are disclosed.

An ambulatory medical device is provided. The ambulatory medical device includes at least one sensor configured to acquire data descriptive of a patient, a memory, a user interface, and at least one processor coupled with the memory, the at least one sensor, and the user interface. The at least one processor is configured to determine whether the ambulatory medical device is within a predefined range of a reference location and to initiate location-specific processing in response to determining that the ambulatory medical device is within the predefined range. The location-specific processing includes at least one of issuing a notification and adapting the user interface.

A system includes an implantable medical device (IMD) and processing circuitry. The IMD includes sensing circuitry configured to sense cardiac electrical signals of a patient, and therapy delivery circuitry configured to deliver demand cardiac pacing to a heart of the patient based on the cardiac electrical signals. The processing circuitry is configured to: determine, for each of a plurality of time units, based on the cardiac electrical signals and the delivery of demand cardiac pacing during the time units, a plurality of metrics indicative of a need for continued delivery of demand cardiac pacing to the heart of the patient. The plurality of metrics includes a metric associated with a duration of one or more pacing episodes during the time unit. The processing circuitry is further configured to generate a graphical representation of the plurality of metrics of the plurality of time units for presentation to a user.

The types of electrode leads that are connected to an implantable medical device are determined based on electrical parameters that are measured at the electrodes that are positioned on the leads. The different types of known electrode leads have different physical electrode arrangements that impact the measured electrical parameters. Properties in the measured electrical parameters that are indicative of the physical arrangements of electrodes of known types of electrode leads are utilized to determine the types of leads that are connected to the implantable medical device.

A kit-of-parts for visualizing by a magnetic resonance imaging (MRI) technique including a functional magnetic resonance imaging (fMRI) technique, regions of a central nervous system of a patient having an implanted active implantable medical device (AIMD) is provided. The kit-of-parts is provided and includes: the AIMD, which can be used exposed to the electromagnetic conditions for MR-images acquisition, an external processing unit for controlling the AIMD, an optical communication lead for establishing a two-way optical communication between the AIMD and an external communication unit which is controlled by the external processing unit.

A patient having an implanted AIMD can be treated in a conventional MR-device for imaging, e.g., a brain region. The other elements of the kit-of-parts allow controlling the functions of the AIMD and following any effects of a stimulation on the brain region thus imaged.